
R&D Investor Event 2023
November 28, 2023 | London, UK

Investors Event Calendar
View recent presentations and learn more about upcoming events.
January 08, 2024
J.P. Morgan Healthcare Conference
San Francisco, USA

Third quarter results 2023
October 24, 2023 | Basel, Switzerland
Media release:
English (PDF 0.4 MB) | Deutsch (PDF 0.4 MB) | Français (PDF 0.5 MB)
Interim financial report (PDF 0.6 MB)
Download the podcast (MP3 33 MB)
Download the interactive presentation (PDF 3.5 MB)
Novartis Q3 2023 Impact and Sustainability Update (PDF 1.0 MB)

Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG Updates: November 2023 (PDF 1.0 MB) | August 2023 (PDF 0.3 MB) | May 2023 (PDF 1.9 MB) | February 2023 (PDF 0.9 MB)
Latest updates: Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB) | Materiality Assessment
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.

Novartis Annual Reporting Suite
Read and download our integrated report, annual regulatory filings, and other disclosures.
Media Releases
Latest Novartis Kisqali® NATALEE analysis reinforces 25% reduction in risk of recurrence across broad population of patients with early breast cancer; supports regulatory submissions
Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH
Novartis upgrades mid-term sales growth guidance, showcases its differentiated innovative medicines strategy and robust pipeline at R&D Day
Novartis AG
Lichtstrasse 35
CH-4056 Basel, Switzerland